These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 12681496)
1. Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design. Haro I; Pérez S; García M; Chan WC; Ercilla G FEBS Lett; 2003 Apr; 540(1-3):133-40. PubMed ID: 12681496 [TBL] [Abstract][Full Text] [Related]
2. [Features of antigen-antibody interaction during use of linear synthetic peptides and multipeptide antigen modeling antigenic determinants of hepatitis A virus]. Kruglov IV; Simonova TV; Perez JA; Haro I Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):31-4. PubMed ID: 19459474 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virus. Pintó RM; González-Dankaart JF; Sánchez G; Guix S; Gómara MJ; García M; Haro I; Bosch A FEBS Lett; 1998 Oct; 438(1-2):106-10. PubMed ID: 9821968 [TBL] [Abstract][Full Text] [Related]
4. Anti-hepatitis A virus antibody response elicited in mice by different forms of a synthetic VP1 peptide. Haro I; Pinto RM; Gonzalez-Dankaart JF; Perez JA; Reig F; Bosch A Microbiol Immunol; 1995; 39(7):485-90. PubMed ID: 8569533 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, lipophilic derivatization and interaction with liposomes of HAV-VP3 (102-121) sequence by using spectroscopic techniques. Garcia M; Pujol M; Reig F; Alsina MA; Haro I Analyst; 1996 Nov; 121(11):1583-8. PubMed ID: 8952449 [TBL] [Abstract][Full Text] [Related]
6. Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection. Gómara MJ; Riedemann S; Vega I; Ibarra H; Ercilla G; Haro I J Immunol Methods; 2000 Feb; 234(1-2):23-34. PubMed ID: 10669766 [TBL] [Abstract][Full Text] [Related]
7. Synthetic peptides for the immunodiagnosis of hepatitis A virus infection. Gauna A; Losada S; Lorenzo M; Bermúdez H; Toledo M; Pérez H; Chacón E; Noya O J Immunol Methods; 2015 Dec; 427():1-5. PubMed ID: 26321053 [TBL] [Abstract][Full Text] [Related]
8. Genetic diversity of hepatitis A virus in China: VP3-VP1-2A genes and evidence of quasispecies distribution in the isolates. Wang H; Zheng H; Cao J; Zhou W; Yi Y; Jia Z; Bi S PLoS One; 2013; 8(9):e74752. PubMed ID: 24069343 [TBL] [Abstract][Full Text] [Related]
9. Antigenic epitopes of the hepatitis A virus polyprotein. Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261 [TBL] [Abstract][Full Text] [Related]
10. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. Bachrach HL; Moore DM; McKercher PD; Polatnick J J Immunol; 1975 Dec; 115(6):1636-41. PubMed ID: 171309 [TBL] [Abstract][Full Text] [Related]
11. Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries. Mattioli S; Imberti L; Stellini R; Primi D J Virol; 1995 Sep; 69(9):5294-9. PubMed ID: 7543581 [TBL] [Abstract][Full Text] [Related]
12. Liposomes as vehicles for the presentation of a synthetic peptide containing an epitope of hepatitis A virus. García M; Alsina MA; Reig F; Haro I Vaccine; 1999 Sep; 18(3-4):276-83. PubMed ID: 10506652 [TBL] [Abstract][Full Text] [Related]
13. Detection of Antibodies against Hepatitis A Virus (HAV) by a Surface Plasmon Resonance (SPR) Biosensor: A New Diagnosis Tool Based on the Major HAV Capsid Protein VP1 (SPR-HAVP1). Santos GMCD; Alves CR; Pinto MA; Amado Leon LA; Souza-Silva F Sensors (Basel); 2021 May; 21(9):. PubMed ID: 34063564 [TBL] [Abstract][Full Text] [Related]
14. The expression, purification, and immunogenicity of a new chimeric virus-like particle. Kui X; Sun M; Xie T; Wang W; Jiang L; Yan M; Ma K; Li H Viral Immunol; 2009 Feb; 22(1):49-56. PubMed ID: 19210228 [TBL] [Abstract][Full Text] [Related]
15. Structure of the hepatitis A virion: peptide mapping of the capsid region. Wheeler CM; Robertson BH; Van Nest G; Dina D; Bradley DW; Fields HA J Virol; 1986 May; 58(2):307-13. PubMed ID: 3009847 [TBL] [Abstract][Full Text] [Related]
16. Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology. Gómara MJ; Ercilla G; Alsina MA; Haro I J Immunol Methods; 2000 Dec; 246(1-2):13-24. PubMed ID: 11121543 [TBL] [Abstract][Full Text] [Related]
17. Expression and immunogenic analysis of recombinant polypeptides derived from capsid protein VP1 for developing subunit vaccine material against hepatitis A virus. Jang KO; Park JH; Lee HH; Chung DK; Kim W; Chung IS Protein Expr Purif; 2014 Aug; 100():1-9. PubMed ID: 24816194 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis in Albanian children: molecular analysis of hepatitis A virus isolates. Gabrieli R; Sanchez G; Macaluso A; Cenko F; Bino S; Palombi L; Buonomo E; Pinto RM; Bosch A; Divizia M J Med Virol; 2004 Apr; 72(4):533-7. PubMed ID: 14981754 [TBL] [Abstract][Full Text] [Related]
19. CD4+ T Cell Immune Response to VP1 and VP3 in BK Virus Infected Recipients of Renal Transplantation. Fan Y; Bai H; Qian Y; Sun Z; Shi B Surg Infect (Larchmt); 2019 Apr; 20(3):236-243. PubMed ID: 30707648 [TBL] [Abstract][Full Text] [Related]
20. Identification of a conserved B-cell epitope on duck hepatitis A type 1 virus VP1 protein. Wu X; Li X; Zhang Q; Wulin S; Bai X; Zhang T; Wang Y; Liu M; Zhang Y PLoS One; 2015; 10(2):e0118041. PubMed ID: 25706372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]